The Relationship Among Changes in Brain Network Activation in Adult Outpatients With Major Depressive Disorder
Status:
Completed
Trial end date:
2019-01-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to explore patterns of Brain Network Activation (BNA) changes
from baseline to endpoint on 1) efficacy of core symptoms of Major Depressive Disorder (MDD)
and 2) improvement of cognitive dysfunction with acute treatment with flexible dose
vortioxetine in adult outpatients with MDD and subjective complaints of cognitive
dysfunction.
Phase:
Phase 4
Details
Lead Sponsor:
Rush University Medical Center
Collaborators:
ElMindA Ltd Takeda Pharmaceuticals North America, Inc.